Astrana Health Price to Free Cash Flow Ratio 2016-2026 | ASTH
Historical price to free cash flow ratio values for Astrana Health (ASTH) since 2016.
| Astrana Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-06-18 | 39.17 | 0.00 | |
| 2025-12-31 | 24.81 | 0 | 0.00 |
| 2025-09-30 | 28.35 | $1.96 | 14.48 |
| 2025-06-30 | 24.88 | $2.46 | 10.10 |
| 2025-03-31 | 31.01 | $1.08 | 28.70 |
| 2024-12-31 | 31.53 | $0.92 | 34.25 |
| 2024-09-30 | 57.94 | $1.46 | 39.79 |
| 2024-06-30 | 40.56 | $1.04 | 38.95 |
| 2024-03-31 | 41.99 | $1.12 | 37.65 |
| 2023-12-31 | 38.30 | $0.85 | 45.29 |
| 2023-09-30 | 30.85 | $2.42 | 12.74 |
| 2023-06-30 | 31.60 | $1.33 | 23.68 |
| 2023-03-31 | 36.47 | $1.00 | 36.34 |
| 2022-12-31 | 29.59 | $1.30 | 22.80 |
| 2022-09-30 | 39.00 | $-0.84 | 0.00 |
| 2022-06-30 | 38.59 | $0.91 | 42.29 |
| 2022-03-31 | 48.47 | $1.04 | 46.52 |
| 2021-12-31 | 73.48 | $1.13 | 65.27 |
| 2021-09-30 | 91.05 | $1.35 | 67.55 |
| 2021-06-30 | 62.81 | $1.40 | 44.87 |
| 2021-03-31 | 27.09 | $1.68 | 16.08 |
| 2020-12-31 | 18.27 | $1.20 | 15.19 |
| 2020-09-30 | 17.94 | $1.39 | 12.95 |
| 2020-06-30 | 16.50 | $1.26 | 13.07 |
| 2020-03-31 | 12.92 | $0.20 | 65.09 |
| 2019-12-31 | 18.41 | $0.35 | 53.05 |
| 2019-09-30 | 17.62 | $0.08 | 221.36 |
| 2019-06-30 | 16.71 | $-0.28 | 0.00 |
| 2019-03-31 | 18.32 | $0.42 | 43.30 |
| 2018-12-31 | 19.85 | $0.64 | 30.94 |
| 2018-09-30 | 22.07 | $1.33 | 16.65 |
| 2018-06-30 | 25.86 | $1.24 | 20.87 |
| 2018-03-31 | 15.95 | $1.12 | 14.24 |
| 2017-12-31 | 24.00 | $1.74 | 13.80 |
| 2017-09-30 | 9.75 | $1.22 | 7.99 |
| 2017-06-30 | 10.00 | $0.84 | 11.96 |
| 2017-03-31 | 9.00 | $0.73 | 12.32 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $1.536B | $3.182B |
| Astrana Health is a provider-centric, technology-powered healthcare company. It operates an integrated healthcare delivery platform which enables providers to participate in value-based care arrangements. Astrana Health, formerly known as Apollo Medical Holdings Inc., is based in ALHAMBRA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |